Insider trades
Andrew D. Dickinson, CFO of Gilead Sciences GILD, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $3.4M. The latest trade was on 06/15.
Andrew D. Dickinson
CFO
- Company
- Gilead Sciences GILD
- First filing
- 23/01/26
- Trades
- 131 trades
- Buys / sales
- 0 / 28
- 12-month net buying
- −$3.4M
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Gilead SciencesGILD | Open-market sale10b5-1 plan | 06/15 | 06/16 | 3,000 sh | $125.40 | $376,200 | −1.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 05/15 | 05/18 | 3,000 sh | $132.27 | $396,810 | −1.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 04/15 | 04/16 | 3,000 sh | $140.96 | $422,880 | −1.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 03/16 | 03/17 | 3,000 sh | $144.23 | $432,690 | −1.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 02/17 | 02/18 | 3,000 sh | $154.43 | $463,290 | −1.8% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 01/15 | 01/16 | 3,000 sh | $124.31 | $372,930 | −2.0% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 3,000 sh | $122.00 | $366,000 | −1.9% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 2,500 sh | $125.23 | $313,075 | −1.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 2,500 sh | $118.08 | $295,200 | −1.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/09/15 | 25/09/16 | 2,500 sh | $113.57 | $283,925 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 2,500 sh | $118.53 | $296,325 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/07/15 | 25/07/16 | 2,500 sh | $111.03 | $277,575 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/06/16 | 25/06/17 | 2,500 sh | $110.17 | $275,425 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/05/15 | 25/05/16 | 2,500 sh | $99.82 | $249,550 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/04/15 | 25/04/16 | 2,500 sh | $106.40 | $266,000 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/03/17 | 25/03/18 | 2,500 sh | $110.53 | $276,325 | −1.4% |
GILD | Open-market sale10b5-1 plan | 25/03/10 | 25/03/12 | 17,929 sh2 trades | $118.17avg. | $2,118,687.3 | −9.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/02/18 | 25/02/19 | 2,500 sh | $104.09 | $260,225 | −1.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/02/12 | 25/02/13 | 137,676 sh | $102.22 | $14,073,240.72 | −44.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/01/31 | 25/02/03 | 142,180 sh | $97.22 | $13,822,739.6 | −52.3% |